Clinical Trial Update: Anakinra to Prevent Post-infarction Remodeling [Phase 3]

View source ↗

Summary

Phase 3 trial assessing anakinra to prevent post-infarction remodeling in ST-segment elevation myocardial infarction has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: ST Segment Elevation Acute Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2010-08-24